TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts June 14, 2013
TCL Archive ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network May 30, 1997
